03.04.2013 - AstraZeneca boosted its early-stage pipeline of experimental heart drugs on Wednesday by buying privately held U.S. biotechnology company AlphaCore Pharma, which is developing a...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)